vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.

SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $47.7M, roughly 1.1× IRONWOOD PHARMACEUTICALS INC). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs -4.8%, a 30.2% gap on every dollar of revenue. Over the past eight quarters, SMARTFINANCIAL INC.'s revenue compounded faster (15.4% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.

IRWD vs SMBK — Head-to-Head

Bigger by revenue
SMBK
SMBK
1.1× larger
SMBK
$53.8M
$47.7M
IRWD
Higher net margin
SMBK
SMBK
30.2% more per $
SMBK
25.4%
-4.8%
IRWD
Faster 2-yr revenue CAGR
SMBK
SMBK
Annualised
SMBK
15.4%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRWD
IRWD
SMBK
SMBK
Revenue
$47.7M
$53.8M
Net Profit
$-2.3M
$13.7M
Gross Margin
Operating Margin
14.3%
Net Margin
-4.8%
25.4%
Revenue YoY
-47.3%
Net Profit YoY
-200.9%
21.6%
EPS (diluted)
$0.01
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
SMBK
SMBK
Q1 26
$53.8M
Q4 25
$47.7M
$53.3M
Q3 25
$122.1M
$51.1M
Q2 25
$85.2M
$49.2M
Q1 25
$41.1M
$46.8M
Q4 24
$90.5M
$46.8M
Q3 24
$91.6M
$44.2M
Q2 24
$94.4M
$40.4M
Net Profit
IRWD
IRWD
SMBK
SMBK
Q1 26
$13.7M
Q4 25
$-2.3M
$13.7M
Q3 25
$40.1M
$13.7M
Q2 25
$23.6M
$11.7M
Q1 25
$-37.4M
$11.3M
Q4 24
$2.3M
$9.6M
Q3 24
$3.6M
$9.1M
Q2 24
$-860.0K
$8.0M
Operating Margin
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
14.3%
31.3%
Q3 25
61.8%
33.2%
Q2 25
53.2%
29.0%
Q1 25
-70.7%
29.0%
Q4 24
34.8%
26.5%
Q3 24
28.0%
24.3%
Q2 24
26.5%
25.6%
Net Margin
IRWD
IRWD
SMBK
SMBK
Q1 26
25.4%
Q4 25
-4.8%
25.7%
Q3 25
32.8%
26.8%
Q2 25
27.7%
23.8%
Q1 25
-90.9%
24.0%
Q4 24
2.5%
20.6%
Q3 24
4.0%
20.7%
Q2 24
-0.9%
19.8%
EPS (diluted)
IRWD
IRWD
SMBK
SMBK
Q1 26
$0.81
Q4 25
$0.01
$0.81
Q3 25
$0.23
$0.81
Q2 25
$0.14
$0.69
Q1 25
$-0.23
$0.67
Q4 24
$0.03
$0.57
Q3 24
$0.02
$0.54
Q2 24
$-0.01
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
SMBK
SMBK
Cash + ST InvestmentsLiquidity on hand
$215.5M
$346.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$562.2M
Total Assets
$396.9M
$5.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
SMBK
SMBK
Q1 26
$346.1M
Q4 25
$215.5M
$464.4M
Q3 25
$140.4M
$557.1M
Q2 25
$92.9M
$365.1M
Q1 25
$108.5M
$423.0M
Q4 24
$88.6M
$387.6M
Q3 24
$88.2M
$192.9M
Q2 24
$105.5M
$342.8M
Total Debt
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
Q3 25
$199.5M
$1.3M
Q2 25
$199.3M
$7.0M
Q1 25
$199.2M
$7.6M
Q4 24
$199.0M
$8.1M
Q3 24
$198.8M
$9.0M
Q2 24
$198.6M
$12.7M
Stockholders' Equity
IRWD
IRWD
SMBK
SMBK
Q1 26
$562.2M
Q4 25
$-261.8M
$552.4M
Q3 25
$-264.2M
$538.4M
Q2 25
$-308.2M
$519.0M
Q1 25
$-334.1M
$505.8M
Q4 24
$-301.3M
$491.3M
Q3 24
$-311.3M
$489.0M
Q2 24
$-321.7M
$472.5M
Total Assets
IRWD
IRWD
SMBK
SMBK
Q1 26
$5.9B
Q4 25
$396.9M
$5.9B
Q3 25
$396.1M
$5.8B
Q2 25
$342.9M
$5.5B
Q1 25
$327.2M
$5.4B
Q4 24
$350.9M
$5.3B
Q3 24
$389.5M
$4.9B
Q2 24
$395.6M
$4.9B
Debt / Equity
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
Q3 25
0.00×
Q2 25
0.01×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
SMBK
SMBK
Operating Cash FlowLast quarter
$74.6M
Free Cash FlowOCF − Capex
$74.6M
FCF MarginFCF / Revenue
156.3%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
$74.6M
$61.7M
Q3 25
$47.6M
$16.9M
Q2 25
$-15.1M
$14.0M
Q1 25
$20.0M
$14.3M
Q4 24
$15.2M
$52.7M
Q3 24
$9.9M
$12.4M
Q2 24
$33.5M
$16.5M
Free Cash Flow
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
$74.6M
$59.3M
Q3 25
$47.6M
$16.6M
Q2 25
$-15.1M
$13.2M
Q1 25
$19.9M
$13.4M
Q4 24
$46.3M
Q3 24
$9.9M
$11.3M
Q2 24
$33.4M
$15.4M
FCF Margin
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
156.3%
111.3%
Q3 25
39.0%
32.4%
Q2 25
-17.7%
26.9%
Q1 25
48.4%
28.5%
Q4 24
98.9%
Q3 24
10.8%
25.7%
Q2 24
35.4%
38.2%
Capex Intensity
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
0.0%
4.5%
Q3 25
0.0%
0.6%
Q2 25
0.0%
1.6%
Q1 25
0.1%
2.0%
Q4 24
0.0%
13.7%
Q3 24
0.0%
2.4%
Q2 24
0.1%
2.7%
Cash Conversion
IRWD
IRWD
SMBK
SMBK
Q1 26
Q4 25
4.50×
Q3 25
1.19×
1.23×
Q2 25
-0.64×
1.20×
Q1 25
1.27×
Q4 24
6.74×
5.47×
Q3 24
2.71×
1.36×
Q2 24
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

SMBK
SMBK

Net Interest Income$45.9M85%
Noninterest Income$7.9M15%

Related Comparisons